OPS/OC/ONDQA/OGD - NIHS

More documents

Recommendations

Info

$Allergies to cross-reactive plant proteins. Latex-fruit ... - NIHS$

Question-based Review: Implementing Quality by Design Lawrence X. Yu, Ph.D. Director for Science Office of Generic Drugs, <strong>OPS</strong>, CDER Food and Drug Administration Opinions expressed in this presentation are those of the speakers and do not necessarily reflect the views or policies of the FDA 1
QbR is a System Generic Drug Application Quality by Design QbR Questions Quality Overall Summary Post-marketing management 2
Page 1 and 2: 添付資料 3 FDA visit agenda
Page 3 and 4: 添付資料 4-a FDA 後発医
Page 23 and 24: 添付資料 4-b FDA 後発医
Page 29: 添付資料 4-b FDA 後発医
Page 33 and 34: Janet Woodcock on QbD J. Woodcock.
Page 35 and 36: ISPE PQLI on QbD, Sept. 14, 2007
Page 37 and 38: Overview of QbD Labeled Use Safety
Page 39 and 40: Target Product Quality Profile: Beg
Page 41 and 42: Identifying Critical Material Attri
Page 43 and 44: Critical Quality Attribute • “A
Page 45 and 46: Design Space • Design Space - The
Page 47 and 48: Controlling Input Materials and Man
Page 49 and 50: QbR Questions Provides a Roadmap
Page 51 and 52: How Does QbR Implement QbD Product
Page 53 and 54: How Does QbR Implement QbD Material
Page 55 and 56: How Does QbR Implement QbD Process
Page 57 and 58: Conclusion • The FDA OGD has deve
Page 59 and 60: 2.3.P.2.4 Container Closure System
Page 61 and 62: 添付資料 4-e FDA 新医薬

OPS/OC/ONDQA/OGD - NIHS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?